These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 38342020)

  • 1. Molecular mechanism of Jianpiyifei II granules in the treatment of chronic obstructive pulmonary disease: Network pharmacology analysis, molecular docking, and experimental assessment.
    Xie D; Quan J; Yu X; Liang Z; Chen Y; Wu L; Lin L; Fan L
    Phytomedicine; 2024 Apr; 126():155273. PubMed ID: 38342020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematical strategy for quality markers screening of different methods processing Platycodonis radix based on phytochemical analysis and the impact on Chronic Obstructive Pulmonary Disease.
    Bai T; Guo J; Deng Y; Zheng Y; Shang J; Zheng P; Liu M; Yang M; Zhang J
    J Ethnopharmacol; 2024 Jan; 319(Pt 2):117311. PubMed ID: 37827295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective Effect of Jianpiyifei II Granule against Chronic Obstructive Pulmonary Disease via NF-
    Fan L; Chen R; Li L; Liang Z; Yu X; Huang K; Yin S; Wu L; Chen Y; Xu Y; Wang Q; Lin L
    Evid Based Complement Alternat Med; 2018; 2018():4265790. PubMed ID: 30174706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uncovering the action mechanism of Shenqi Tiaoshen formula in the treatment of chronic obstructive pulmonary disease through network pharmacology, molecular docking, and experimental verification.
    Qinjun Y; Dandan Y; Hui W; Yating G; Xinheng W; Di WU; Jiabing T; Chuanbo W; Zegeng LI
    J Tradit Chin Med; 2024 Aug; 44(4):770-783. PubMed ID: 39066538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with JianPiYiFei II granules for patients with moderate to very severe chronic obstructive pulmonary disease: A 52-week randomised, double-blinded, placebo-controlled, multicentre trial.
    Chen Y; Gong X; Zhou M; Xu Y; Fan F; Xiao J; Liu L; Shi K; Li S; Zhuo J; Chen Z; Yu X; Fan L; Chen Y; Wu L; Lin L
    Phytomedicine; 2022 Jun; 100():154057. PubMed ID: 35349835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanism of Ganke Granules intervening acute lung injury based on network pharmacology and experimental verification].
    Liang H; Li XY; Zhang XW; Bao YW; Ding ML; Yuan QH; He CS; Zeng N
    Zhongguo Zhong Yao Za Zhi; 2024 Apr; 49(8):2197-2209. PubMed ID: 38812235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploration the mechanism of Shenling Baizhu San in the treatment of chronic obstructive pulmonary disease based on UPLC-Q-TOF-MS/MS, network pharmacology and in vitro experimental verification.
    Gao Z; Wang J; Lu G; Wu Q; Wang S; Wu X; Ou C; Wu Z; Yu H; Wang Y
    J Ethnopharmacol; 2024 Apr; 324():117728. PubMed ID: 38216101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of Action of Bu-Fei-Yi-Shen Formula in Treating Chronic Obstructive Pulmonary Disease Based on Network Pharmacology Analysis and Molecular Docking Validation.
    Wu L; Chen Y; Yi J; Zhuang Y; Cui L; Ye C
    Biomed Res Int; 2020; 2020():9105972. PubMed ID: 33313323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Jian-Pi-Yi-Fei granule suppresses airway inflammation in mice induced by cigarette smoke condensate and lipopolysaccharide.
    Tang CY; Tang SL; Huang KF; Xu J; Yu H; Lin L
    Indian J Pharmacol; 2019; 51(4):263-268. PubMed ID: 31571713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated plasma pharmacochemistry and network pharmacology to explore the mechanism of Gerberae Piloselloidis Herba in treatment of allergic asthma.
    Zhou K; Lu D; You J; Liu T; Sun J; Lu Y; Pan J; Li Y; Liu C
    J Ethnopharmacol; 2022 Nov; 298():115624. PubMed ID: 35970314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Jianpiyifei II Granules Suppress Apoptosis of Bronchial Epithelial Cells in Chronic Obstructive Pulmonary Disease
    Fan L; Li L; Yu X; Liang Z; Cai T; Chen Y; Xu Y; Hu T; Wu L; Lin L
    Front Pharmacol; 2020; 11():581. PubMed ID: 32425799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Network Pharmacology and Experimental Verification Reveal the Regulatory Mechanism of Chuanbeimu in Treating Chronic Obstructive Pulmonary Disease.
    Xian M; Xu J; Zheng Y; Zhang L; Zhao J; Chen J; Li S; Lin L; Zhong Y; Yang Z; Xie T; Huang L; Ding Y
    Int J Chron Obstruct Pulmon Dis; 2024; 19():799-813. PubMed ID: 38529478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic characterization of the effective constituents and molecular mechanisms of Ardisiae Japonicae Herba using UPLC-Orbitrap Fusion MS and network pharmacology.
    Feng S; Yuan J; Zhao D; Li R; Liu X; Tian Y; Li J
    PLoS One; 2022; 17(6):e0269087. PubMed ID: 35704651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Jingfang granule alleviates Pseudomonas aeruginosa-induced acute lung inflammation through suppression of STAT3/IL-17/NF-κB pathway based on network pharmacology analysis and experimental validation.
    Gu M; Su W; Dai J; Wang J; Jia X; Yao J; Zhang G; Zhu Q; Pang Z
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116899. PubMed ID: 37454750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gleditsiae sinensis fructus Pills combined with Jujubae fructus attenuate chronic bronchitis via regulation of AGE-RAGE signaling pathway.
    Wang CC; Kang L; Zuo BL; Peng X; Li HW; Zhou N; Li K
    J Ethnopharmacol; 2024 Jan; 319(Pt 1):117191. PubMed ID: 37717840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electroacupuncture inhibits IL-17/IL-17R and post-receptor MAPK signaling pathways in a rat model of chronic obstructive pulmonary disease.
    Zhang XF; Xiang SY; Lu J; Li Y; Zhao SJ; Jiang CW; Liu XG; Liu ZB; Zhang J
    Acupunct Med; 2021 Dec; 39(6):663-672. PubMed ID: 33715422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Network pharmacology and experiments in vivo and in vitro reveal that the Jia-Wei-Bu-Shen-Yi-Qi formula (JWBSYQF) and its active ingredient baicalein ameliorate BLM-induced lung fibrosis in mice via PI3K/Akt signaling pathway.
    Shi H; Deng L; Zhou Y; Yu H; Huang X; Chen M; Lei Y; Dong J
    J Ethnopharmacol; 2023 Oct; 315():116691. PubMed ID: 37247682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Network pharmacology, molecular docking and experimental verification of the mechanism of huangqi-jixuecao herb pair in treatment of peritoneal fibrosis.
    Dai H; Shan Y; Yu M; Wang F; Zhou Z; Sun J; Sheng L; Huang L; Sheng M
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116874. PubMed ID: 37437794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation into the potential mechanism and therapeutic targets of Cangzhu Erchen decoction for the treatment of chronic obstructive pulmonary disease based on bioinformatics and network pharmacology.
    Gu X; Ju J; Chen Q; Ge M; Huang H
    Medicine (Baltimore); 2024 Aug; 103(33):e39338. PubMed ID: 39151493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Network pharmacology prediction and molecular docking analysis reveal the mechanism of modified Bushen Yiqi formulas on chronic obstructive pulmonary disease.
    Choi W; Wu Y; Li Y; Dong J
    J Gene Med; 2024 Jan; 26(1):e3607. PubMed ID: 37795773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.